Global Single-Cell Analysis Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights By Type of Product, by Type of Cell, by Type of Technique, by Application and by End User
The global single-cell analysis market is witnessing high growth due to increasing geriatric population, high prevalence of infectious diseases, growing focus on personalized medicines, and technological advancements in single-cell analysis products. The increased use of microfluidics in single-cell analysis instruments is also leading to its higher adoption. Moreover, increasing conferences and meetings of single-cell analysis such as 4th annual single cell analysis congress 2016, and Keystone Symposia Conference: Single Cell Omics - Program, are further promoting the growth of the market. However, high cost of single-cell analysis products and intellectual property right issues restrict innovations in assay kits and are the key restraints associated with the growth of the global market.
Single Cell Analysis Market
On the basis of single-cell analysis instrument, the NGS systems segment held the largest share in the global market in 2015. Among the various type of cell in single-cell analysis, the human cells segment held the largest share in the global market in 2015. The single-cell analysis market globally had largest application in cancer and the largest end users were hospitals and diagnostic laboratories in 2015.
The growing geriatric population across the globe are expected to increase the demand for single-cell analysis products. The geriatric population is more vulnerable to infections and immunological diseases, which is having high positive impact on market growth. According to UN report, the number of people aged 60 years or over is projected to grow by 56% from 901 million in 2015 to reach 1.4 billion, globally by 2030. It further reported that by 2050 the global geriatric population is expected to more than double of its size than in 2015, reaching nearly 2.1 billion. Thus, the growing incidence of geriatric population is driving the growth of this market.
High prevalence of infectious diseases is one of the major factor responsible for the growth of single-cell analysis market such as HIV, HCV etc. For instance, according to Joint United Nations Programme on HIV/AIDS (UNAIDS), approximately 36.7 million people worldwide in 2015 are living with HIV infection. Various research applications in single-cell analysis market helps in deriving different treatment methodologies to treat these infections.
The global single-cell analysis market is segmented on the basis of type of product as consumables and instruments. On the basis of consumables, global single-cell analysis market is segmented into beads, microplates, reagents, assay kits, and others. On the basis of instruments, global single-cell analysis market is segmented into flow cytometers, NGS systems, PCR instruments, microscopes, and Others. The consumables segment is expected to grow at the highest CAGR during 2016-2022. The reagents segment held the largest share in the global market in 2015.
Based on type of cell, market is segmented into human cells, animal cells and microbial cells. Based on type of techniques, market is segmented into flow cytometry, Next-generation sequencing (NGS), polymerase chain reaction (PCR), microscopy, and others. Based on application, market is segmented into research applications and diagnostic applications. The research applications are further segmented into cancer, immunology, neurology, stem cells, and other applications. The diagnostic applications are further segmented into noninvasive prenatal diagnosis (NIPD), In vitro fertilization (IVF), and Circulating tumor cells (CTC’s). And based on type of end users of single-cell analysis, the market is segmented into academic & research institutes, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centers.
Geographically, North America accounts for the largest single-cell analysis market due to growing aging population and technological advancements in single-cell analysis products. The market is expected to witness fastest growth in Asia during the forecast period, due to the vast awareness from increasing conferences and meetings to market payers and presence of large pool of infection affected patients in this region.
Some of the key companies operating in the global single-cell analysis market include Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Nanostring technologies, Agilent Technologies, Fluidigm Corporation.
Our reports have been used by over 10K customers, including:
The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Market growth is driven by the rising prevalence of cancer, the rapid growth in the biotechnology & biopharmaceutical industries, growing focus on R&D, recent developments in stem cell...
Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast,...
3D Cell Culture Market Research Report by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture, Scaffold-based 3D Cell Culture, and Scaffold-free 3D Cell Culture), by Application (Cancer, Drug Discovery, Stem Cell Research, Tissue Engineering and Regenerative Medicine, and Toxicology), by End User - Global...
- The Autologous Stem Cell and Non-Stem Cell-Based Therapies market is anticipated to grow with a CAGR of nearly 14.26%, during the forecast period. Certain factors that are driving the market growth include rising prevalence of targeted diseases, the introduction of novel autologous stem cell-based therapies in regenerative medicine and increasing...
The South &Central America cancer vaccines market was valued at US$ 191.89 million in 2019 and is projected to reach US$ 627.49 million by 2027; it is expected to grow at a CAGR of 16.3% during the forecast period. Increasing number of cancer patients, emergence of market players operatingin the cancer vaccinesmarket, and robust research...
200 pages •
By The Business Research Company
• Nov 2020
Stem Cell Therapy Global Market Report 2020-30: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global stem cell therapy market. This report focuses on stem cell therapy market which is experiencing strong growth. The report gives a guide to the...
300 pages •
By The Business Research Company
• Nov 2020
Cell Therapy Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cell therapy market. This report focuses on cell therapy market which is experiencing strong growth. The report gives a guide to the cell therapy...
Hepatocyte Growth Factor - Pipeline Review, H2 2020 Summary According to the recently published report ’Hepatocyte Growth Factor - Pipeline Review, H2 2020’; Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. Hepatocyte Growth...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.